Cefpodoxime Proxetil EP Impurity A
Product Description
CAT No.
ALN-C089002
CAS No.
80210-62-4
Mol. F.
C15H17N5O6S2
Mol. Wt.
427.5
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : (6R,7R)-7-[[(2Z)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (as per EP)
Smiles : O=C(C(N12)=C(COC)CS[C@]2([H])[C@H](NC(/C(C3=CSC(N)=N3)=N\OC)=O)C1=O)O
Inchi : InChI=1S/C21H27N5O9S2/c1-9(2)33-21(30)35-10(3)34-19(29)15-11(6-31-4)7-36-18-14(17(28)26(15)18)24-16(27)13(25-32-5)12-8-37-20(22)23-12/h8-10,14,18H,6-7H2,1-5H3,(H2,22,23)(H,24,27)/b25-13-/t10?,14-,18-/m1/s1
Synonym : Cefpodoxime ; Cefpodoxime acid
Technical Data
Reference
Stability indicating HPLC method development and validation for the simultaneous determination of Cefpodoxime Proxetil and Ofloxacin in its dosage forms
By Ghode, Prashant D.; Pawar, Sunil P.nFrom International Journal of Pharma and Bio Sciences (2015), 6(2), 183-193
Stability indicating method development degradation studies and validation of cefpodoxime proxetil by RP-HPLC method
By Kamalesh, G.; Madhuri, D.; Nagarajan, G. – From International Journal for Pharmaceutical Research Scholars (2014), 3(4), 269-275, 7 pp..
Characterization of impurities in cefpodoxime proxetil using LC-MS (n)
By Li Jin; Zhang Dousheng; Hu Changqin – From Acta pharmaceutica Sinica. B (2014), 4(4), 322-32
RFQ